Salute e Benessere

Heat Gun Sales Surge As Home Improvement Projects Soar, the Heat Gun Market to…

Heat guns have emerged as one of the most versatile industrial tools. However, various types of heat guns are available in the market, and end users can choose the tools as per their requirements and convenience. Heat guns can be segmented into variable and dual temperature settings by product type. The variable temperature heat can achieve a varying temperature range, which can be monitored on the LCD or LED display provided by the tool. The dual-temperature heat guns include two temperature…
PR Newswire
16/05/2023

Automatic Pool Cleaner Market to be Worth $3.63 Billion by 2028, Adoption of…

Browse In-Depth TOC on the Automatic Pool Cleaner Market ��� Browse In-Depth TOC on the Automatic Pool Cleaner Market ��� 90 - Tables 75 - Charts 257 – Pages The increasing popularity of swimming pools and the growth of residential and commercial infrastructure have led to a surge in demand for pool-related equipment, including automatic pool cleaners. Robotics, suction, and pressure are among the major types of automatic pool cleaners that use...
PR Newswire
16/05/2023

Casino Group Communication

Extension of the solicitation period for certain creditors and bondholders of the Casino Group regarding the possibility of initiating conciliation proceedings Paris, 16 May 2023In response to today's reports in the press and broadcast media and further to the press release issued on 24 April 2023, with regard to the solicitation of consents from certain Casino Group creditors and bondholders regarding the possibility of initiating conciliation proceedings to guide its upcoming...
Nasdaq GlobeNewswire
16/05/2023

Monthly information related to total number of voting rights and shares…

Monthly information related to total number of voting rights and shares composing the share capital _May 15, 2023 .Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – FranceListing markets:Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) &Nasdaq Global Select Market in the United-States (Symbol : ERYP) Website : www.erytech.com DateTotal of shares composing...
Nasdaq GlobeNewswire
16/05/2023

eureKING, the first European SPAC in healthcare dedicated to biomanufacturing…

Skyepharma ,a France-based CDMO with over 20 years of innovation and development expertise , is a renowned player in the global biopharma and consumer health industries. The company's unique offerin the biomanufacturing process spans all stages of clinical development , marketing and product lifecycle .The proposed transaction would represent the first cornerstone of eureKING's project to pursue bolt-on acquisitions to add innovative companies...
Nasdaq GlobeNewswire
16/05/2023

USD 165 Billion Growth in Musculoskeletal Disorders Drugs Market Size - Industry…

Musculoskeletal Disorders Drugs Market: Overview Musculoskeletal Disorders Drugs Market: Overview Musculoskeletal systems comprise body organs like ligaments, cartilage, bones, connective tissues, and tendons. The skeleton is a necessary framework for soft tissues and muscles. These components together support the body weight and help in maintaining posture and body movement. Different types of conditions and disorders can cause issues in the musculoskeletal system. Factors like birth...
PR Newswire
16/05/2023

Growing Demand for Orthotic Devices Propels the Global Market towards $30.3…

Orthotic Devices Market: Overview Orthotic Devices Market: Overview Orthotic devices find massive use in neuropathy management. These medical devices help in reducing pain and are used in effectively managing patients having spinal cord injuries as well as brachial plexus injuries. Moreover, orthotic equipment is externally applied equipment that is utilized for aiding, mobilizing, and altering skeletal structure as well as the neuromuscular system which is weak, injured, and ineffective...
PR Newswire
16/05/2023

Transactions in connection with share buy-back program

Company announcement no. 19 - 2316 May 2023 Transactions in connection with share buy-back program On 8 May 2023 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company announcement no. 17 - 23. The program will be executed in accordance with the principles of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbor rules...
Nasdaq GlobeNewswire
16/05/2023

Psychosis in Parkinson's and Alzheimer's Disease Market to Observe Stunning…

Key Takeaways from the Psychosis in Parkinson's and Alzheimer's Disease Market Report Key Takeaways from the Psychosis in Parkinson's and Alzheimer's Disease Market Report Discover which therapies are expected to grab the major psychosis in Parkinson's and Alzheimer's disease market share @ Psychosis in Parkinson's and Alzheimer's Disease Market Report Psychosis in Parkinson's and Alzheimer's Disease Overview Psychosis is a group of symptoms that affect the mind and indicate a...
PR Newswire
16/05/2023

Kimera® Labs Receives FDA Phase I/IIa IND Approval For Its MSC Exosomes Human…

Kimera Labs will recruit COVID-19 patients for the IV administration of its exosome products commencing in June. This Phase I/IIa study will thoroughly investigate the safety and clinical efficacy of its advanced exosome products and technology. The Company anticipates completing its Phase I/IIa trial in a matter of months, and then to seek approval to commence the final Phase 3 study. Kimera's exosomes are produced at its 28,000 state-of-the-art FDA GMP-inspected manufacturing facilities in…
PR Newswire
16/05/2023

Chlorpheniramine Maleate Market to Reach $751.4 Million, Globally, by 2032 at…

Download Free Sample Copy of the Report- https://www.alliedmarketresearch.com/request-sample/3975 Download Free Sample Copy of the Report-https://www.alliedmarketresearch.com/request-sample/3975 Prime determinants of growth Increase in the prevalence of allergic disorders such as allergic rhinitis, common cold, watery eyes, urticaria and various others, increase in urbanization and change in lifestyles and surge in technological advancement drive the growth of the global...
PR Newswire
16/05/2023

JOY GROUP Celebrates Its Debut on WWD Beauty Inc Top 100

Each year, WWD Beauty Inc. releases its definitive list of the world's top 100 beauty companies, based on sales in the previous calendar year. Recognized as the "Beauty Industry Practitioner's Guide", this annual ranking is one of the most authoritative in the global beauty industry. Each year, WWD Beauty Inc. releases its definitive list of the world's top 100 beauty companies, based on sales in the previous calendar year. Recognized as the "Beauty Industry Practitioner's…
PR Newswire
16/05/2023

NCCN Global Policy Leader Named Co-Chair of Global Health Council Roundtable…

"NCDs—including cancer, heart disease, chronic respiratory disease, and diabetes—are responsible for 74% of all deaths around the world," said Winckworth-Prejsnar, citing data from the World Health Organization1. "The vast majority of these deaths are happening in low- and middle-income countries. At NCCN, we recognize our responsibility to do whatever we can to increase equitable cancer outcomes. Our work to standardize and elevate cancer care in partnership with experts in…
PR Newswire
16/05/2023

Akari Therapeutics to Participate in A.G.P.'s Virtual Healthcare Conference

NEW YORK and LONDON, May16, 2023(GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced that the company will participate in Alliance Global Partners' Virtual Healthcare Conference being held May 23-24, 2023. During the event, the Akari management team will attend 1:1 investor meetings. About Akari TherapeuticsAkari Therapeutics, plc (Nasdaq: AKTX) is a...
Nasdaq GlobeNewswire
16/05/2023

Philips' image-guided navigation increases safety during coronary interventions…

Late-breaking data from DCR4Contrast study presented at EuroPCR 2023 and SCAI 2023 also shows an average reduction in the total number of angiograms obtained during each procedure of 26.3% [1]Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced late-breaking data from the DCR4Contrast (Dynamic Coronary Roadmap for Contrast Reduction) trial, the largest ever randomized controlled multicenter clinical trial to...
Nasdaq GlobeNewswire
16/05/2023

Alkermes Highlights Data From Psychiatry Portfolio at Spring 2023 Scientific…

"Alkermes is excited to participate in key scientific meetings this spring that bring together thought leaders and healthcare providers from across the field of psychiatry," said Craig Hopkinson, M.D., Chief Medical Officer and Executive Vice President of Research & Development at Alkermes. "These meetings represent important venues for information sharing as we continue to advance the body of evidence supporting our medicines for the treatment of schizophrenia and bipolar I…
PR Newswire
16/05/2023

MediBeacon Inc. Appoints Dr. Steve Miller as Chief Medical Officer

Dr. Miller formerly served as executive vice president and chief clinical officer at Cigna, where he led the company's clinical policy, quality, and performance efforts. Dr. Miller was chief medical officer at Express Scripts in advance of Cigna's acquisition of the company. Prior to Express Scripts Dr. Miller was vice president and chief medical officer at Barnes-Jewish Hospital, Washington University School of Medicine in St. Louis. He has been a member of the MediBeacon board of directors…
PR Newswire
16/05/2023

Peer-reviewed translational research paves the way for first-in-class autotaxin…

IOA-289 is a novel ATX inhibitor with a unique chemical structure, excellent potency and an attractive non-clinical safety profile. It has a unique binding mode that places it in an inhibitor class of its own. Avoidance of interaction with the catalytic site likely contributes to the improved safety profile of IOA-289 compared to other ATX inhibitors, avoiding toxicities seen with first-generation entities. IOA-289 is a novel ATX inhibitor with a unique chemical structure, excellent potency…
PR Newswire
16/05/2023

Immatics Announces First Quarter 2023 Financial Results and Business Update

ACTengine® IMA203 TCR-T monotherapy against PRAME showed 67% confirmed ORR in an interim clinical update on heavily pre-treated 11 patients in Phase 1b dose expansion Cohort A with median duration of response not reached at a median follow-up time of 8.5 months at data cut-offObjective responses observed across multiple tumor types including checkpoint-refractory cutaneous melanoma, platinum-resistant ovarian cancer, uveal melanoma, head and neck cancer and synovial sarcomaCohort A IMA203...
Nasdaq GlobeNewswire
16/05/2023

New Report Meningococcal Vaccine Market Expected to Reach US$ 7.4 Billion by…

Meningococcal disease is caused by bacteria called as Neisseria meningitidis and includes infection of spinal cord, brain lining and bloodstream. It usually spreads from nearby infected areas such as the nasal sinuses or from the cerebrospinal fluid. Meningococcal disease is caused by bacteria called as Neisseria meningitidis and includes infection of spinal cord, brain lining and bloodstream. It usually spreads from nearby infected areas such as the nasal sinuses or from the cerebrospinal...
PR Newswire
16/05/2023

Bridge Clinic opens new clinic for IVF services in Central London

Based in a dedicated building in Euston on the site of the former Blossom House School, the clinic offers a range of services for patients allowing them to make informed choices on their treatment. These include In Vitro Fertilisation (IVF), Intracytoplasmic sperm injection (ICSI), Intrauterine insemination (IUI), Frozen Embryo Transfer (FET), Ovulation Induction (OI), Egg Freezing, and Sperm Freezing. Based in a dedicated building in Euston on the site of the formerBlossom House School, the...
PR Newswire
16/05/2023

Pharmaceutical Suppositories Market Statistics 2023-2032: Market Size, Growth…

North America was the largest region in the pharmaceutical suppositories market, accounting for 39.1% of the total in 2022. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the pharmaceutical suppositories market will be Asia Pacific and Western Europe. North America was thelargest regionin thepharmaceutical suppositories market, accounting for 39.1% of the total in 2022. It was followed byAsia Pacific,...
PR Newswire
16/05/2023

Nuclear Medicine Market to be Worth $22.3 Billion by 2030: Grand View Research…

Read 170 page market research report, "Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters, Brachytherapy)), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030", published by Grand View Research. Read 170 page market research report, " Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics (SPECT, PET), Therapeutics (Alpha…
PR Newswire
16/05/2023

Health and Fitness App Market Expected to reach US$ 18.7 billion by 2030 with a…

Order free Sample Copy of the Report: Order free Sample Copy of the Report: https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4685 (The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, Table of Contents, Graphical introduction of regional analysis, Top players in the market with their revenue analysis and our research methodology.) Our Sample Report Includes: Updated...
PR Newswire
16/05/2023
Altri  Comunicati